News & Media

 Keep up to date with all of our latest news.

News & Media Menu

Today, we will be sharing positive pharmacology and safety #data highlighting the progress of our lead asset SPVN06, a breakthrough mutation-agnostic #genetherapy approach targeting #IRDs, at the @ASGCTherapy 25th Annual Meeting 2022. Find out more here:

Our CFO Stanislas Piot and Senior Director of IR Nathalie Delair-Trepo are meeting with #investors and industry peers this week (16-18 May) at the #BioEquityEurope Conference hosted by @BioCentury in Milan. More here: